Industry News - Tag: GlaxoSmithKline

You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.

Haleon will target greater household penetration
Premium

3 March 2022

Increasing household penetration for its brands will be the “largest opportunity” for GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, according to Brian McNamara, chief executive officer designate of Haleon.

Read the full story

Switches and naturals are high on Haleon’s agenda
Premium

3 March 2022

Switching medicines from prescription to non-prescription status and launching naturals will be high on the agenda at GlaxoSmithKline (GSK) Consumer Healthcare following its demerger as Haleon in July 2022, says Brian McNamara, chief executive officer designate of Haleon.

Read the full story

Consumer Healthcare grows by a tenth at GSK
Premium

15 February 2022

GlaxoSmithKline (GSK) is in “full countdown mode” to demerging its Consumer Healthcare business, according to chief executive officer Emma Walmsley, who was speaking as the business reported sales up by a tenth at constant exchange rates in the fourth quarter of 2021.

Read the full story